Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ROCK CREEK PHARMACEUTICALS, INC.v312939_ex99-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): 5/10/12

 

 

 

 
STAR SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-15324   52-1402131

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

4470 Cox Road

Glen Allen, Virginia 23060

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (804) 527-1970

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

 

Item 7.01. Regulation FD Disclosure

 

On May 10, 2012, Star Scientific, Inc. (the “Company”) filed a press release that it deems important to security holders. The press release is furnished as Exhibit 99.1 to this Current Report and is incorporated by reference into this Item 7.01 of Form 8-K.

 

The information in this Current Report is furnished under Item 7.01 of Form 8-K and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Furthermore, the information in this Current Report shall not be deemed to be incorporated by reference into the filings of the registrant under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filings.

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

     
Exhibit No.   Description
99.1   Star Scientific, Inc.’s press release dated May 10, 2012.

 

 
 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       
STAR SCIENTIFIC, INC.  
   
Date: May 11, 2012  
     
By:  

/s/ Paul L. Perito 

 
    Paul L. Perito  
    Chairman of the Board, President and Chief Operating Officer